Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS Genet. 2014 Jan;10(1):e1004059. doi: 10.1371/journal.pgen.1004059. Epub 2014 Jan 2.

DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structure.

Author information

  • 1The Centre for Individualized Medicine, Linköping University Hospital, Linköping University, Linköping, Sweden.
  • 2The Centre for Individualized Medicine, Linköping University Hospital, Linköping University, Linköping, Sweden ; Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • 3Mathematical Sciences, Chalmers University of Technology, University of Gothenburg, Gothenburg, Sweden.
  • 4Department of Electrical Engineering and Computer Science, University of Tennessee, Knoxville, Tennessee, United States of America.
  • 5National Institute for Computational Sciences, University of Tennessee, Knoxville, Tennessee, United States of America.

Abstract

Altered DNA methylation patterns in CD4(+) T-cells indicate the importance of epigenetic mechanisms in inflammatory diseases. However, the identification of these alterations is complicated by the heterogeneity of most inflammatory diseases. Seasonal allergic rhinitis (SAR) is an optimal disease model for the study of DNA methylation because of its well-defined phenotype and etiology. We generated genome-wide DNA methylation (N(patients) = 8, N(controls) = 8) and gene expression (N(patients) = 9, Ncontrols = 10) profiles of CD4(+) T-cells from SAR patients and healthy controls using Illumina's HumanMethylation450 and HT-12 microarrays, respectively. DNA methylation profiles clearly and robustly distinguished SAR patients from controls, during and outside the pollen season. In agreement with previously published studies, gene expression profiles of the same samples failed to separate patients and controls. Separation by methylation (N(patients) = 12, N(controls) = 12), but not by gene expression (N(patients) = 21, N(controls) = 21) was also observed in an in vitro model system in which purified PBMCs from patients and healthy controls were challenged with allergen. We observed changes in the proportions of memory T-cell populations between patients (N(patients) = 35) and controls (N(controls) = 12), which could explain the observed difference in DNA methylation. Our data highlight the potential of epigenomics in the stratification of immune disease and represents the first successful molecular classification of SAR using CD4(+) T cells.

PMID:
24391521
[PubMed - indexed for MEDLINE]
PMCID:
PMC3879208
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk